retatrutide trial results news today This data from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Retatrutide approval: FDA status, clinical

assessed six patients with bile acid diarrhea secondary to ileal resection who received ED for 815 days, and they showed a reduction in their fecal bile acid excretion with marked improvement in their diarrhea and reduction in stool frequency, volume, and urgency [41]

Discuss any GLP-1 decision with a licensed clinician

Glucagon-like peptide-1 (GLP-1) receptor agonistsmedications originally developed for type 2 diabetesare emerging as a potential treatment option for PCOS due to their effects on insulin sensitivity, weight management, and hormonal regulation

Until we have more data, some medical professionals recommended sticking with lower doses (0.4 to 1mg) of folate supplementation a day along with B12 for depression